Earlier, the company revealed its intention to offer at least 5% of its shares on the Egyptian Exchange to retail and institutional investors, meeting free float requirements on the exchange.
EFG Hermes and Renaissance Capital are managing the transaction, while White & Case, Clifford Chance and Ogier are counsel
In 2015, EFG Hermes concluded advisory on IDH’s initial public offering (IPO) on the London Stock Exchange (LSE), offering 43.5% of the company.
IDH has a strong presence in Jordan, Sudan, and Nigeria, with a total of 468 branches. The Company aims to be a leading healthcare provider in every community and region that it serves, becoming every doctor and patient’s first choice for quality, accurate diagnostic testing and cost effective services.